TOPK as a novel determinant of radiosensitivity
<p>Radiotherapy is the use of ionising radiation to induce localised DNA damage to cancerous tissues, leading to cell death and disease control. In order to maximise tumour growth control and to limit damage of the healthy surrounding tissues and the consequent side effects for the patient, mo...
Main Author: | Pirovano, GM |
---|---|
Other Authors: | McKenna, G |
Format: | Thesis |
Language: | English |
Published: |
2016
|
Subjects: |
Similar Items
-
Modelling secondary cancer risk from photon and proton therapy in medulloblastoma
by: Madkhali, A
Published: (2018) -
Ovarian Cancer Radiosensitivity: What Have We Understood So Far?
by: Amelia Barcellini, et al.
Published: (2022-12-01) -
Animal Experimentation in Oncology and Radiobiology: Arguments for and Against Following a Critical Literature Review
by: William-Philippe Girard, et al.
Published: (2022-06-01) -
Using functional and computational genomics approaches to study the cross-talk between radiosensitivity and HIF-1α activation
by: Van Ess, AN
Published: (2023) -
The role of the CtIP gene as a genetic susceptibility factor for radiation leukaemogenesis
by: Nasilowska, A
Published: (2014)